About
Rivaroxaban is a direct oral anticoagulant (DOAC) that selectively inhibits factor Xa, a crucial enzyme in the coagulation cascade. By blocking factor Xa, it effectively reduces thrombin generation and subsequent clot formation. This mechanism provides a predictable anticoagulant effect, making it a valuable agent for preventing and treating various thromboembolic conditions without the need for routine coagulation monitoring, which is often required with older anticoagulants like warfarin. Its rapid onset of action and relatively short half-life contribute to its clinical utility in managing patients at risk of blood clots.
This medication is widely used to prevent serious cardiovascular events such as stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also indicated for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Furthermore, rivaroxaban plays a significant role in thromboprophylaxis following major orthopedic surgeries, such as hip or knee replacement, and in reducing the risk of major adverse cardiovascular events in patients with coronary artery disease or peripheral artery disease. Its broad spectrum of indications underscores its importance in modern antithrombotic therapy.
Uses
- Prevention of stroke and systemic embolism in non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT).
- Treatment of pulmonary embolism (PE).
- Prevention of DVT/PE after orthopedic surgery.
Directions For Use
Take exactly as prescribed by your doctor. Some doses should be taken with food.
Benefits
- Effective in preventing blood clots.
- Does not require routine blood monitoring.
- Convenient oral administration.
- Rapid onset of action.
- Reduces risk of stroke and systemic embolism.
- Approved for various thrombotic conditions.
Side Effects
- Bleeding (e.g., nosebleeds, gum bleeding)
- Bruising easily
- Anemia
- Nausea
- Abdominal pain
- Indigestion
- Dizziness
- Headache
- Fatigue
- Peripheral edema
- Increased liver enzymes
- Hypersensitivity reactions
Safety Measures
- Alcohol - Avoid excessive alcohol consumption as it can increase the risk of bleeding when combined with rivaroxaban.
- Pregnancy - Not recommended during pregnancy due to the potential for fetal bleeding and teratogenicity.
- Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and cause bleeding in the infant.
- Liver - Contraindicated in patients with severe liver disease associated with coagulopathy. Use with caution in moderate impairment.
- Kidney - Use with caution and dose adjustment may be required in patients with moderate to severe renal impairment.
- Lung - Generally safe, but caution in patients with active pulmonary bleeding or conditions predisposing to it.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!